Reducing the length of hospital stay for patients undergoing . . . Study aim, design and settings This study is a multicenter, prospective, randomized controlled clinical trial designed to test the superiority of the general anesthesia-based ERAS pathway in term of the total hospital length of stay (LOS) compared with the current clinical practice for patients undergoing TKA, conducted from February 1, 2021 to January 31, 2023 at West China Hospital of
Randomized Controlled Trials - PMC The strongest evidence for causality between the exposure or intervention under study and the outcome observed comes from prospective experimental designs that randomly assign interventions to trial participants Randomized controlled trials (RCTs) have traditionally been viewed as the gold standard of clinical trial design, residing at the top
How to start and develop a multicenter, prospective . . . Design of a multicenter, prospective, randomized controlled and non-inferiority multicenter study Generally, PCA studies are designed with the aim of trying to demonstrate that a medical or surgical treatment is superior to the standard or conventional one
A Prospective, Multi-Center, Randomized, Controlled Clinical . . . Our research will look at how well UC-MSCs prevent GVHD following haplo-HSCT, as well as recurrence rates after transplantation, transplant-related issues, and the state of immunological reconstruction the frequency, severity, 1- and 2-year survival rates, cumulative death rates, and the occurrence of aGVHD and cGVHD Real-time tracking will be
A prospective, multi-center, randomised controlled trial for . . . We conducted a multicenter, prospective, randomised, controlled trial in which 126 patients with an uncrossable lesion were randomly (1:1 randomization) assigned to treatment first with the Blimp balloon or low-profile balloon